Intelligence / Healthtech / De Novo Grants / Vitestro
Approvalsnovel device granted (FDA De Novo)19 Aug 2026
Vitestro
19 Aug 2026: Novel device granted (FDA De Novo) · Aletta® Autonomous Robotic Phlebotomy Device (ARPD) (Gen1 US). Recorded in the openFDA device 510(k) (De Novo decisions).
- Granted
- 19 Aug 2026
- Device
- Aletta® Autonomous Robotic Phlebotomy Device (ARPD) (Gen1 US)
- Specialty
- General Hospital
- Product Code
- SIW
- Country
- Netherlands
- Location
- Utrecht, Netherlands
- Submitted
- 2025-09-26
- Reference
- DEN250046
What this signal means
A De Novo grant creates a new device category: reimbursement coding, distribution, clinical evidence, manufacturing scale-up and sales hires follow.
- 2 added in the 30 days to 19 Nov 2026.
- Neurology leads (10); 29% went to makers outside the US.
Reach them with AOS
Find the decision makers at Vitestro
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.
Across AOS Research
Other records for Vitestro in our registers.
More in General Hospital
De Novo Grants
1 MaySterisnovel device granted (FDA De Novo) · Prolystica Pass Thru Disinfectant WipesApprovals23 DecHai Solutionsnovel device granted (FDA De Novo) · QIKCAP SystemApprovals4 AprPrapela, Inc.novel device granted (FDA De Novo) · Prapela SVS hospital bassinet pad (model P01)Approvals19 MarNanosonics Limitednovel device granted (FDA De Novo) · CORIS SystemApprovals
Source: openFDA device 510(k) (De Novo decisions), data to 19 Nov 2026. Every De Novo classification FDA granted in the last 24 months: a novel device with no legally marketed predicate, which creates a new device type and product code. AOS shows what the public record says; it does not verify or endorse the company.